Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

7.360 -0.070 (-0.94%)
Streaming Delayed Price Updated: 9:34 AM EST, Dec 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
4 Analysts Assess Bicycle Therapeutics: What You Need To Know ↗
 
Via Benzinga
News headline image
Bicycle (BCYC) Q2 Revenue Falls 69% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews ↗
 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts ↗
 
Via Benzinga
News headline image
Analyst Expectations For Bicycle Therapeutics's Future ↗
 
Via Benzinga
News headline image
Deep Dive Into Bicycle Therapeutics Stock: Analyst Perspectives (9 Ratings) ↗
 
Via Benzinga
News headline image
Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
Breaking Down Bicycle Therapeutics: 8 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Navigating 11 Analyst Ratings For Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients ↗
Bicycle Therapeutics presented data on zelenectide pevedotin, highlighting enhanced efficacy in cancer patients with NECTIN4 gene amplification. 
Via Benzinga
News headline image
BCYC: A Promising Play In The Biotech Sector ↗
The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a... 
Via Talk Markets
Topics ETFs
News headline image
In-Depth Examination Of 5 Analyst Recommendations For Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings For Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
Expert Ratings For Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone ↗
RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safety over competitors. The analyst projects ~$2 billion in peak sales by 2033... 
Via Benzinga
News headline image
BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
BCYC stock results show that Bicycle Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views ↗
 
Via Benzinga
Topics Earnings Stocks
News headline image
Gold Falls Sharply; US Composite PMI Surges In May ↗
 
Via Benzinga
News headline image
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 4 Takes On Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
Forecasting The Future: 4 Analyst Projections For Bicycle Therapeutics ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗
BCYC stock results show that Bicycle Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.